Evidence mapPaperPMID 41451314Full record

ReviewDiabetes, metabolic syndrome and obesity : targets and therapy2025

The Rise and Rise of Type 1 and Type 2 Diabetes in Youth.

Mark D DeBoer

Abstract readReview
In one paragraph

Review in Diabetes, metabolic syndrome and obesity : targets and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Mark D DeBoerDivision of Pediatric Endocrinology and Center for Diabetes Technology, University of Virginia, Charlottesville, VA, USA.ORCID 0000-0003-1462-591X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite having very different underlying etiologies, an unfortunate similarity between Type 1 diabetes (T1D) and Type 2 diabetes (T2D) is the ongoing increase in incidence and prevalence in youth in both types of diabetes over the past several decades. This mini-review highlights recent studies documenting the increases in T1D and T2D in the US and worldwide. These trends underscore the need for healthcare providers and families to have a low index of suspicion for diabetes, as well as the ongoing need for improved means of preventing and treating diabetes in youth.

Indexed as

adolescencechildhoodincidencetype 1 diabetestype 2 diabetes

Identifiers

PMID41451314
PMCPMC12731209

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.